JPRN-UMIN000010997尚未招募未知
Intravitreal aflibercept injection for exudative age-related macular degeneration - Intravitreal aflibercept injection for AMD
Department of Ophthalmology, Fukushima Medical University School of Medicine0 个研究点目标入组 50 人开始时间: 2013年6月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)The greatest linear dimension (GLD)>12 Macular Photocoagulation Study Disc Areas 2)Presence of subretinal hemorrhage, scar or macular fibrosis(>50% lesion area) 3)Prior treatment with anti-VEGF drugs, photodynamic therapy 4)Prior treatment with dexamethasone(within 6 months) or triamcinolone (within 30 days), intraocular surgery(within 3 months 5)Active intraocular inflammation 6)Hypersensitivity or allergy to fluoresceinor or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products 7)Patients who the doctor in charge judges are ineligible for the study
研究者
相似试验
已完成
不适用
Study of intravitreal aflibercept for exudative age-related macular degeneratioAge-related macular degenerationJPRN-UMIN000012126Department of Ophthalmology, Jikei University School of Medicine30
尚未招募
3 期
To investigate the role of Intravitreal Aflibercept (Eylea) in the treatment of patients whose wet Age related Macular degeneration is not adequately controlled with conventional anti VEGF (intravitreal Avastin or Lucentis) treatment.ACTRN12613001020774Greenlane Clinical Centre Auckland District Health Board50
已完成
4 期
The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO)Branch retinal vein occlusionJPRN-UMIN000023200Department of Ophthalmology, Akita University50
已完成
不适用
Intravitreal injection of anti vascular endothelial growth factor agent, Lucentis (ranibizumab), for the treatment of retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000013975agoya University hospital ophtalmoligy30
已完成
不适用
Combination therapy of intravitreal aflibercept and topical bromfenac for RVOretinal vein occlusionJPRN-UMIN000022988Juntendo Urayasu Hospital40